Ensysce Biosciences Stock Market Value
| ENSC Stock | USD 0.72 0.07 8.70% |
| Symbol | Ensysce |
Will Biotechnology sector continue expanding? Could Ensysce diversify its offerings? Factors like these will boost the valuation of Ensysce Biosciences. Projected growth potential of Ensysce fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Ensysce Biosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (6.35) | Revenue Per Share | Quarterly Revenue Growth (0.86) | Return On Assets | Return On Equity |
Investors evaluate Ensysce Biosciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Ensysce Biosciences' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Ensysce Biosciences' market price to deviate significantly from intrinsic value.
It's important to distinguish between Ensysce Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ensysce Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Ensysce Biosciences' market price signifies the transaction level at which participants voluntarily complete trades.
Ensysce Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ensysce Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ensysce Biosciences.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Ensysce Biosciences on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Ensysce Biosciences or generate 0.0% return on investment in Ensysce Biosciences over 90 days. Ensysce Biosciences is related to or competes with Soligenix, Oragenics, Kala Pharmaceuticals, Xenetic Biosciences, AIM ImmunoTech, Vyne Therapeutics, and Kazia Therapeutics. Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for... More
Ensysce Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ensysce Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ensysce Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.29) | |||
| Maximum Drawdown | 23.86 | |||
| Value At Risk | (10.78) | |||
| Potential Upside | 5.94 |
Ensysce Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ensysce Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ensysce Biosciences' standard deviation. In reality, there are many statistical measures that can use Ensysce Biosciences historical prices to predict the future Ensysce Biosciences' volatility.| Risk Adjusted Performance | (0.19) | |||
| Jensen Alpha | (1.43) | |||
| Total Risk Alpha | (1.80) | |||
| Treynor Ratio | (1.27) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ensysce Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ensysce Biosciences January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.19) | |||
| Market Risk Adjusted Performance | (1.26) | |||
| Mean Deviation | 3.67 | |||
| Coefficient Of Variation | (369.31) | |||
| Standard Deviation | 5.0 | |||
| Variance | 24.97 | |||
| Information Ratio | (0.29) | |||
| Jensen Alpha | (1.43) | |||
| Total Risk Alpha | (1.80) | |||
| Treynor Ratio | (1.27) | |||
| Maximum Drawdown | 23.86 | |||
| Value At Risk | (10.78) | |||
| Potential Upside | 5.94 | |||
| Skewness | 0.1439 | |||
| Kurtosis | 0.8523 |
Ensysce Biosciences Backtested Returns
Ensysce Biosciences secures Sharpe Ratio (or Efficiency) of -0.3, which denotes the company had a -0.3 % return per unit of risk over the last 3 months. Ensysce Biosciences exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Ensysce Biosciences' Variance of 24.97, standard deviation of 5.0, and Mean Deviation of 3.67 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.07, which means a somewhat significant risk relative to the market. Ensysce Biosciences returns are very sensitive to returns on the market. As the market goes up or down, Ensysce Biosciences is expected to follow. At this point, Ensysce Biosciences has a negative expected return of -1.55%. Please make sure to confirm Ensysce Biosciences' jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Ensysce Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.82 |
Very good predictability
Ensysce Biosciences has very good predictability. Overlapping area represents the amount of predictability between Ensysce Biosciences time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ensysce Biosciences price movement. The serial correlation of 0.82 indicates that around 82.0% of current Ensysce Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.82 | |
| Spearman Rank Test | 0.83 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ensysce Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ensysce Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ensysce Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ensysce Biosciences Stock:Check out Ensysce Biosciences Correlation, Ensysce Biosciences Volatility and Ensysce Biosciences Alpha and Beta module to complement your research on Ensysce Biosciences. For information on how to trade Ensysce Stock refer to our How to Trade Ensysce Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Ensysce Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.